Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Tema Heart & Health ETF (NQ:HRTS)

36.45 -0.08 (-0.21%)

Official Closing Price Updated: 4:15 PM EDT, Jul 17, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,301
Open	36.70
Bid (Size)	18.26 (200)
Ask (Size)	54.76 (200)
Prev. Close	36.52
Today's Range	36.41 - 36.70
52wk Range	27.23 - 37.57
Shares Outstanding	N/A
Dividend Yield	1.30%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing ↗

February 13, 2025

The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.

Via Stocktwits

Keros Therapeutics Stock Heads For Record Low After Dosing Halt In Pulmonary Disease Trial, Retail Buzz Spikes ↗

January 15, 2025

The company’s stock declined nearly 60% in 2024 and has lost an additional 21% in 2025, with this latest setback further dampening investor confidence.

Via Stocktwits

Performance

YTD	+3.0%	+3.0%
1 Month	+7.4%	+7.4%
3 Month	+6.1%	+6.1%
6 Month	+2.0%	+2.0%
1 Year	+28.9%	+28.9%

More News

EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss ↗

December 20, 2024

Via Benzinga

EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen' ↗

September 25, 2024

Via Benzinga

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' ↗

July 18, 2024

Via Benzinga

EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO ↗

July 07, 2024

Via Benzinga

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients ↗

July 05, 2024

Via Investor's Business Daily

Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply ↗

May 29, 2024

Via Benzinga

Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test ↗

April 17, 2024

Via Investor's Business Daily

Healthcare ETFs For The Weight-Loss Drug Boom And Beyond ↗

April 08, 2024

Via Talk Markets

Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗

February 23, 2024

Via Investor's Business Daily

Ozempic, Weygovy – Obesity And Heart Health Constitute A Major Market That Is Only Growing ↗

January 29, 2024

Via Benzinga

Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market ↗

December 04, 2023

Via Benzinga

EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads ↗

December 01, 2023

Via Benzinga

Frequently Asked Questions

Is Tema Heart & Health ETF publicly traded?

Yes, Tema Heart & Health ETF is publicly traded.

What exchange does Tema Heart & Health ETF trade on?

Tema Heart & Health ETF trades on the Nasdaq Stock Market

What is the ticker symbol for Tema Heart & Health ETF?

The ticker symbol for Tema Heart & Health ETF is HRTS on the Nasdaq Stock Market

What is the current price of Tema Heart & Health ETF?

The current price of Tema Heart & Health ETF is 36.45

When was Tema Heart & Health ETF last traded?

The last trade of Tema Heart & Health ETF was at 07/17/26 04:15 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.